Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic tools

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 1, 2011, Pages 133-140

  Craig, Sonya E L ^a   Brady Kalnay, Susann M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cell adhesion; Cell cell interactions; Receptor protein tyrosine phosphatase; RPTPs

Indexed keywords

NOTCH RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE ALPHA; PROTEIN TYROSINE PHOSPHATASE DELTA; PROTEIN TYROSINE PHOSPHATASE EPSILON; PROTEIN TYROSINE PHOSPHATASE SIGMA; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER TISSUE; CARCINOGENESIS; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CRYSTAL STRUCTURE; HUMAN; LIGAND BINDING; MOLECULAR DIAGNOSIS; NONHUMAN; ONCOGENE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

EID: 79953008859     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152011794941244     Document Type: Article

References (78)

1. Andersen, J. N.; Mortensen, O. H.; Peters, G. H.; Drake, P. G.; Iversen, L. F.; Olsen, O. H.; Jansen, P. G.; Andersen, H. S.; Tonks, N. K.; Møller, N. P. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell Biol., 2001, 21 (21), 7117-7136.
2. Brady-Kalnay, S. M.; Tonks, N. K. Protein tyrosine phosphatases as adhesion receptors. Curr. Opin. Cell Biol., 1995, 7 (5), 650-657.
3. Brady-Kalnay, S. M. Protein Tyrosine Phosphatases. In Cell Adhesion: Frontiers in Molecular Biology., Beckerle, M., Ed. Oxford University Press: Oxford, UK., 2001, Vol. 39, pp. 217-258.
4. Kwon, S. K.; Woo, J.; Kim, S. Y.; Kim, H.; Kim, E. Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation. J. Biol. Chem., 2010, 285 (18), 13966-13978.
5. Aricescu, A. R.; McKinnell, I. W.; Halfter, W.; Stoker, A. W. Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol. Cell Biol., 2002, 22 (6), 1881-1892.
6. O'Grady, P.; Thai, T. C.; Saito, H. The laminin-nidogen complex is a ligand for a specific splice isoform of the transmembrane protein tyrosine phosphatase LAR. J. Cell Biol., 1998, 141 (7), 1675-1684.
7. Haj, F.; McKinnell, I.; Stoker, A. Retinotectal ligands for the receptor tyrosine phosphatase CRYPalpha. Mol. Cell Neurosci., 1999, 14 (3), 225-240.
8. Wang, J.; Bixby, J. L. Receptor tyrosine phosphatase-delta is a homophilic, neurite-promoting cell adhesion molecular for CNS neurons. Mol. Cell Neurosci., 1999, 14 (4-5), 370-384.
9. Yang, T.; Bernabeu, R.; Xie, Y.; Zhang, J. S.; Massa, S. M.; Rempel, H. C.; Longo, F. M. Leukocyte antigen-related protein tyrosine phosphatase receptor: a small ectodomain isoform functions as a homophilic ligand and promotes neurite outgrowth. J. Neurosci., 2003, 23 (8), 3353-3363.
10. Chagnon, M. J.; Uetani, N.; Tremblay, M. L. Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases. Biochem. Cell Biol., 2004, 82 (6), 664-675.
11. Brady-Kalnay, S. M.; Flint, A. J.; Tonks, N. K. Homophilic binding of PTPμ, a receptor-type protein tyrosine phosphatase, can mediate cell-cell aggregation. J. Cell Biol., 1993, 122 (4), 961-972.
12. Cheng, J.; Wu, K.; Armanini, M.; O'Rourke, N.; Dowbenko, D.; Lasky, L. A. A novel protein-tyrosine phosphatase related to the homotypically adhering kappa and mu receptors. J. Biol. Chem., 1997, 272 (11), 7264-7277.
13. Gebbink, M. F.; Zondag, G. C.; Wubbolts, R. W.; Beijersbergen, R. L.; van Etten, I.; Moolenaar, W. H. Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase. J. Biol. Chem., 1993, 268 (22), 16101-16104.
14. Sap, J.; Jiang, Y. P.; Friedlander, D.; Grumet, M.; Schlessinger, J. Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding. Mol. Cell Biol., 1994, 14 (1), 1-9.
15. Zondag, G. C.; Koningstein, G. M.; Jiang, Y. P.; Sap, J.; Moolenaar, W. H.; Gebbink, M. F. Homophilic interactions mediated by receptor tyrosine phosphatases mu and kappa. A critical role for the novel extracellular MAM domain. J. Biol. Chem., 1995, 270 (24), 14247-14250.
16. Yu, J.; Becka, S.; Zhang, P.; Zhang, X.; Brady-Kalnay, S. M.; Wang, Z. Tumor-derived extracellular mutations of PTPRT/PTPrho are defective in cell adhesion. Mol. Cancer Res., 2008, 6 (7), 1106-1113.
17. Becka, S.; Zhang, P.; Craig, S. E.; Lodowski, D. T.; Wang, Z.; Brady-Kalnay, S. M. Characterization of the adhesive properties of the type IIb subfamily receptor protein tyrosine phosphatases. Cell Commun. Adhes., 2010, 17 (2), 34-47.
18. Aricescu, A. R.; Siebold, C.; Jones, E. Y. Receptor protein tyrosine phosphatase mu: measuring where to stick. Biochem. Soc. Trans., 2008, 36 (Pt 2), 167-172.
19. Ensslen-Craig, S. E.; Brady-Kalnay, S. M. Receptor protein tyrosine phosphatases regulate neural development and axon guidance. Dev. Biol., 2004, 275 (1), 12-22.
20. Sakurai, T.; Lustig, M.; Nativ, M.; Hemperly, J. J.; Schlessinger, J.; Peles, E.; Grumet, M. Induction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase beta. J. Cell Biol., 1997, 136 (4), 907-918.
21. Peles, E.; Nativ, M.; Campbell, P. L.; Sakurai, T.; Martinez, R.; Lev, S.; Clary, D. O.; Schilling, J.; Barnea, G.; Plowman, G. D.; Grumet, M.; Schlessinger, J. The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell, 1995, 82 (2), 251-260.
22. Milev, P.; Friedlander, D. R.; Sakurai, T.; Karthikeyan, L.; Flad, M.; Margolis, R. K.; Grumet, M.; Margolis, R. U. Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J. Cell Biol., 1994, 127, 1703-1715.
23. Barnea, G.; Grumet, M.; Milev, P.; Silvennoinen, O.; Levy, J. B.; Sap, J.; Schlessinger, J. Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin. J. Biol. Chem., 1994, 269 (20), 14349-14352.
24. Maeda, N.; Nishiwaki, T.; Shintani, T.; Hamanaka, H.; Noda, M. 6B4 proteoglycan/phosphacan, an extracellular variant of receptorlike protein-tyrosine phosphatase zeta/RPTPbeta, binds pleiotrophin/ heparin-binding growth-associated molecule (HB-GAM). J. Biol. Chem., 1996, 271 (35), 21446-21452.
25. Östman, A.; Hellberg, C.; Böhmer, F. D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer, 2006, 6 (4), 307-320.
26. Craig, S. E.; Brady-Kalnay, S. M. Cancer cells cut and run. Cancer Res., 2011, 71(2), 303-309.
27. Fortini, M. E. γ-secretase-mediated proteolysis in cell-surfacereceptor signalling. Nat, Rev. Mol. Cell Biol., 2002, 3 (9), 673-684.
28. Anders, L.; Mertins, P.; Lammich, S.; Murgia, M.; Hartmann, D.; Saftig, P.; Haass, C.; Ullrich, A. Furin-, ADAM 10-, and gammasecretase- mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin's transcriptional activity. Mol. Cell Biol., 2006, 26 (10), 3917-3934.
29. Burgoyne, A. M.; Phillips-Mason, P. J.; Burden-Gulley, S. M.; Robinson, S.; Sloan, A. E.; Miller, R. H.; Brady-Kalnay, S. M. Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration. Cancer Res., 2009, 69 (17), 6960-6968.
30. Chow, J. P.; Fujikawa, A.; Shimizu, H.; Suzuki, R.; Noda, M. Metalloproteinase- and gamma-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z. J. Biol. Chem., 2008, 283 (45), 30879-30889.
31. Haapasalo, A.; Kim, D. Y.; Carey, B. W.; Turunen, M. K.; Pettingell, W. H.; Kovacs, D. M. Preseniliin/gamma-secretasemediated cleavage regulates association of leukocyte-common antigen-related (LAR) receptor tyrosine phosphatase with betacatenin. J. Biol. Chem., 2007, 282 (12), 9063-9072.
32. Gil-Henn, H.; Volohonsky, G.; Elson, A. Regulation of proteintyrosine phosphatases alpha and epsilon by calpain-mediated proteolytic cleavage. J. Biol. Chem., 2001, 276 (34), 31772-31779.
33. Gil-Henn, H.; Volohonsky, G.; Toledano-Katchalski, H.; Gandre, S.; Elson, A. Generation of novel cytoplasmic forms of protein tyrosine phosphatase epsilon by proteolytic processing and translational control. Oncogene, 2000, 19 (38), 4375-4384.
34. Edwards, D. R.; Handsley, M. M.; Pennington, C. J. The ADAM metalloproteinases. Mol. Aspects Med., 2008, 29 (5), 258-289.
35. Kim, Y. S.; Kang, H. Y.; Kim, J. Y.; Oh, S.; Kim, C. H.; Ryu, C. J.; Miyoshi, E.; Taniguchi, N.; Ko, J. H. Identification of target proteins of N-acetylglucosaminyl transferase V in human colon cancer and implications of protein tyrosine phosphatase kappa in enhanced cancer cell migration. Proteomics, 2006, 6 (4), 1187-1191.
36. Streuli, M.; Krueger, N. X.; Ariniello, P. D.; Tang, M.; Munro, J. M.; Blattler, W. A.; Adler, D. A.; Disteche, C. M.; Saito, H. Expression of the receptor-linked protein tyrosine phosphatase LAR: proteolytic cleavage and shedding of the CAM-like extracellular region. EMBO J., 1992, 11 (3), 897-907.
37. Yu, Q.; Lenardo, T.; Weinberg, R. A. The N-terminal and C-terminal domains of a receptor tyrosine phosphatase are associated by non-covalent linkage. Oncogene, 1992, 7 (6), 1051-1057.
38. Serra-Pagès, C.; Saito, H.; Streuli, M. Mutational analysis of proprotein processing, subunit association, and shedding of the LAR transmembrane protein tyrosine phosphatase. J. Biol. Chem., 1994, 269 (38), 23632-23641.
39. Aicher, B.; Lerch, M. M.; Müller, T.; Schilling, J.; Ulrich, A. Cellular redistribution of protein tyrosine phosphatases LAR and PTPsigma by inducible proteolytic processing. J. Cell Biol., 1997, 138, 681-696.
40. Ruhe, J. E.; Streit, S.; Hart, S.; Ullrich, A. EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing. Cell Signal., 2006, 18 (9), 1515-1527.
41. Pulido, R.; Krueger, N. X.; Serra-Pagès, C.; Saito, H.; Streuli, M. Molecular characterization of the human transmembrane proteintyrosine phosphatase delta. Evidence for tissue-specific expression of alternative human transmembrane protein-tyrosine phosphatase delta isoforms. J. Biol. Chem., 1995, 270 (12), 6722-6728.
42. McArdle, L.; Rafferty, M. M.; Satyamoorthy, K.; Maelandsmo, G. M.; Dervan, P. A.; Herlyn, M.; Easty, D. J. Microarray analysis of phosphatase gene expression in human melanoma. Br. J. Dermatol., 2005, 152 (5), 925-930.
43. Yang, T.; Zhang, J. S.; Massa, S. M.; Han, X.; Longo, F. M. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue. Mol. Carcinog., 1999, 25 (2), 139-149.
44. Konishi, N.; Tsujikawa, K.; Yamamoto, H.; Ishida, E.; Nakamura, M.; Shimada, K.; Yane, K.; Yamashita, H.; Noguchi, S. Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas. Br. J. Cancer, 2003, 88 (8), 1223-1228.
45. Ding, L.; Getz, G.; Wheeler, D. A.; Mardis, E. R.; McLellan, M. D.; Cibulskis, K.; Sougnez, C.; Greulich, H.; Muzny, D. M.; Morgan, M. B.; Fulton, L.; Fulton, R. S.; Zhang, Q.; Wendl, M. C.; Lawrence, M. S.; Larson, D. E.; Chen, K.; Dooling, D. J.; Sabo, A.; Hawes, A. C.; Shen, H.; Jhangiani, S. N.; Lewis, L. R.; Hall, O.; Zhu, Y.; Mathew, T.; Ren, Y.; Yao, J.; Scherer, S. E.; Clerc, K.; Metcalf, G. A.; Ng, B.; Milosavljevic, A.; Gonzalez-Garay, M. L.; Osborne, J. R.; Meyer, R.; Shi, X.; Tang, Y.; Koboldt, D. C.; Lin, L.; Abbott, R.; Miner, T. L.; Pohl, C.; Fewell, G.; Haipek, C.; Schmidt, H.; Dunford-Shore, B. H.; Kraja, A.; Crosby, S. D.; Sawyer, C. S.; Vickery, T.; Sander, S.; Robinson, J.; Winckler, W.; Baldwin, J.; Chirieac, L. R.; Dutt, A.; Fennell, T.; Hanna, M.; Johnson, B. E.; Onofrio, R. C.; Thomas, R. K.; Tonon, G.; Weir, B. A.; Zhao, X.; Ziaugra, L.; Zody, M. C.; Giordano, T.; Orringer, M. B.; Roth, J. A.; Spitz, M. R.; Wistuba, II; Ozenberger, B.; Good, P. J.; Chang, A. C.; Beer, D. G.; Watson, M. A.; Ladanyi, M.; Broderick, S.; Yoshizawa, A.; Travis, W. D.; Pao, W.; Province, M. A.; Weinstock, G. M.; Varmus, H. E.; Gabriel, S. B.; Lander, E. S.; Gibbs, R. A.; Meyerson, M.; Wilson, R. K. Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 2008, 455 (7216), 1069-1075.
46. Sato, M.; Takahashi, K.; Nagayama, K.; Arai, Y.; Ito, N.; Okada, M.; Minna, J. D.; Yokota, J.; Kohno, T. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer. Genes Chromosomes Cancer, 2005, 44 (4), 405-414.
47. Solomon, D. A.; Kim, J. S.; Cronin, J. C.; Sibenaller, Z.; Ryken, T.; Rosenberg, S. A.; Ressom, H.; Jean, W.; Bigner, D.; Yan, H.; Samuels, Y.; Waldman, T. Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma. Cancer Res., 2008, 68 (24), 10300-10306.
48. Stallings, R. L.; Nair, P.; Maris, J. M.; Catchpoole, D.; McDermott, M.; O'Meara, A.; Breatnach, F. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res., 2006, 66 (7), 3673-3680.
49. Veeriah, S.; Brennan, C.; Meng, S.; Singh, B.; Fagin, J. A.; Solit, D. B.; Paty, P. B.; Rohle, D.; Vivanco, I.; Chmielecki, J.; Pao, W.; Ladanyi, M.; Gerald, W. L.; Liau, L.; Cloughesy, T. C.; Mischel, P. S.; Sander, C.; Taylor, B.; Schultz, N.; Major, J.; Heguy, A.; Fang, F.; Mellinghoff, I. K.; Chan, T. A. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc. Natl. Acad. Sci. USA, 2009, 106 (23), 9435-9440.
50. Peedicayil, A.; Vierkant, R. A.; Hartmann, L. C.; Fridley, B. L.; Fredericksen, Z. S.; White, K. L.; Elliott, E. A.; Phelan, C. M.; Tsai, Y. Y.; Berchuck, A.; Iversen, E. S., Jr.; Couch, F. J.; Peethamabaran, P.; Larson, M. C.; Kalli, K. R.; Kosel, M. L.; Shridhar, V.; Rider, D. N.; Liebow, M.; Cunningham, J. M.; Schildkraut, J. M.; Sellers, T. A.; Goode, E. L. Risk of ovarian cancer and inherited variants in relapse-associated genes. PLoS One, 2010, 5 (1), e8884.
51. Suárez Pestana, E.; Tenev, T.; Gross, S.; Stoyanov, B.; Ogata, M.; Böhmer, F. D. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells. Oncogene, 1999, 18 (28), 4069-79.
52. Burgoyne, A. M.; Palomo, J. M.; Phillips-Mason, P. J.; Burden-Gulley, S. M.; Major, D. L.; Zaremba, A.; Robinson, S.; Sloan, A. E.; Vogelbaum, M. A.; Miller, R. H.; Brady-Kalnay, S. M. PTPmu suppresses glioma cell migration and dispersal. Neuro. Oncol., 2009, 11 (6), 767-678.
53. Burden-Gulley, S. M.; Gates, T. J.; Burgoyne, A. M.; Cutter, J. L.; Lodowski, D. T.; Robinson, S.; Sloan, A. E.; Miller, R. H.; Basilion, J. P.; Brady-Kalnay, S. M. A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu. Neoplasia, 2010, 12 (4), 305-316.
54. McArdle, L.; Rafferty, M.; Maelandsmo, G. M.; Bergin, O.; Farr, C. J.; Dervan, P. A.; O'Loughlin, S.; Herlyn, M.; Easty, D. J. Protein tyrosine phosphatase genes downregulated in melanoma. J. Invest. Dermatol., 2001, 117 (5), 1255-1260.
55. Flavell, J. R.; Baumforth, K. R.; Wood, V. H.; Davies, G. L.; Wei, W.; Reynolds, G. M.; Morgan, S.; Boyce, A.; Kelly, G. L.; Young, L. S.; Murray, P. G. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood, 2008, 111 (1), 292-301.
56. Harder, K. W.; Moller, N. P.; Peacock, J. W.; Jirik, F. R. Proteintyrosine phosphatase alpha regulates Src family kinases and alters cell-substratum adhesion. J. Biol. Chem., 1998, 273 (48), 31890-31900.
57. Su, J.; Muranjan, M.; Sap, J. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr. Biol., 1999, 9 (10), 505-511.
58. Zeng, L.; D'Alessandri, L.; Kalousek, M. B.; Vaughan, L.; Pallen, C. J. Protein tyrosine phosphatase α (PTPα) and contactin form a novel neuronal receptor complex linked to the intracellular tyrosine kinase fyn. J. Cell Biol., 1999, 147 (4), 707-714.
59. Pallen, C. J. Protein tyrosine phosphatase alpha (PTPalpha): a Src family kinase activator and mediator of multiple biological effects. Curr. Top. Med. Chem., 2003, 3 (7), 821-835.
60. Peles, E.; Schlessinger, J.; Grumet, M. Multi-ligand interactions with receptor-like protein tyrosine phosphatase beta: implications for intercellular signaling. Trends Biochem. Sci., 1998, 23 (4), 121-124.
61. Levy, J. B.; Canoll, P. D.; Silvennoinen, O.; Barnea, G.; Morse, B.; Honegger, A. M.; Huang, J. T.; Cannizzaro, L. A.; Park, S. H.; Druck, T.; Kuebner, K.; Sap, J.; Ehrlich, M.; Musacchio, J. M.; Schlessinger, J. The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system. J. Biol. Chem., 1993, 268 (14), 10573-10581.
62. Foehr, E. D.; Lorente, G.; Kuo, J.; Ram, R.; Nikolich, K.; Urfer, R. Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model. Cancer Res., 2006, 66 (4), 2271-2278.
63. Yamakawa, T.; Kurosawa, N.; Kadomatsu, K.; Matsui, T.; Itoh, K.; Maeda, N.; Noda, M.; Muramatsu, T. Levels of expression of pleiotrophin and protein tyrosine phosphatase zeta are decreased in human colorectal cancers. Cancer Lett., 1999, 135 (1), 91-96.
64. Hägerstrand, D.; Smits, A.; Eriksson, A.; Sigurdardottir, S.; Olofsson, T.; Hartman, M.; Nistér, M.; Kalimo, H.; Östman, A. Gene expression analyses of grade II gliomas and identification of rPTPbeta/zeta as a candidate oligodendroglioma marker. Neuro. Oncol., 2008, 10 (1), 2-9.
65. Müller, S.; Kunkel, P.; Lamszus, K.; Ulbricht, U.; Lorente, G. A.; Nelson, A. M.; von Schack, D.; Chin, D. J.; Lohr, S. C.; Westphal, M.; Melcher, T. A role for receptor tyrosine phosphatase zeta in glioma cell migration. Oncogene, 2003, 22 (43), 6661-6668.
66. Ulbricht, U.; Brockmann, M. A.; Aigner, A.; Eckerich, C.; Müller, S.; Fillbrandt, R.; Westphal, M.; Lamszus, K. Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas. J. Neuropathol. Exp. Neurol., 2003, 62 (12), 1265-1275.
67. Ulbricht, U.; Eckerich, C.; Fillbrandt, R.; Westphal, M.; Lamszus, K. RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo. J. Neurochem., 2006, 98 (5), 1497-1506.
68. Maeda, N.; Noda, M. Involvement of receptor-like protein tyrosine phosphatase zeta/RPTPbeta and its ligand pleiotrophin/heparinbinding growth-associated molecule (HB-GAM) in neuronal migration. J. Cell Biol., 1998, 142 (1), 203-216.
69. Sakurai, T.; Friedlander, D. R.; Grumet, M. Expression of polypeptide variants of receptor-type protein tyrosine phosphatase beta: the secreted form, phosphacan, increases dramatically during embryonic development and modulates glial cell behavior in vitro. J. Neurosci. Res., 1996, 43 (6), 694-706.
70. Adamsky, K.; Schilling, J.; Garwood, J.; Faissner, A.; Peles, E. Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C. Oncogene, 2001, 20 (5), 609-618.
71. Brady-Kalnay, S. M.; Tonks, N. K. Identification of the homophilic binding site of the receptor protein tyrosine phosphatase PTP mu. J Biol. Chem., 1994, 269 (45), 28472-28477.
72. Aricescu, A. R.; Hon, W. C.; Siebold, C.; Lu, W.; van der Merwe, P. A.; Jones, E. Y. Molecular analysis of receptor protein tyrosine phosphatase mu-mediated cell adhesion. EMBO J., 2006, 25 (4), 701-712.
73. Aricescu, A. R.; Siebold, C.; Choudhuri, K.; Chang, V. T.; Lu, W.; Davis, S. J.; van der Merwe, P. A.; Jones, E. Y. Structure of a tyrosine phosphatase adhesive interaction reveals a spacer-clamp mechanism. Science, 2007, 317 (5842), 1217-1220.
74. Cismasiu, V. B.; Denes, S. A.; Reiländer, H.; Michel, H.; Szedlacsek, S. E. The MAM (meprin/A5-protein/PTPmu) domain is a homophilic binding site promoting the lateral dimerization of receptor-like protein-tyrosine phosphatase mu. J. Biol. Chem., 2004, 279 (26), 26922-26931.
75. Wang, Z.; Shen, D.; Parsons, D. W.; Bardelli, A.; Sager, J.; Szabo, S.; Ptak, J.; Silliman, N.; Peters, B. A.; van der Heijden, M. S.; Parmigiani, G.; Yan, H.; Wang, T. L.; Riggins, G.; Powell, S. M.; Willson, J. K.; Markowitz, S.; Kinzler, K. W.; Vogelstein, B.; Velculescu, V. E. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science, 2004, 304 (5674), 1164-1166.
76. Zhang, P.; Becka, S.; Craig, S. E.; Lodowski, D. T.; Brady-Kalnay, S. M.; Wang, Z. Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation. Cell Commun. Adhes., 2009, 16 (5-6), 146-153.
77. Maeda, N.; Ichihara-Tanaka, K.; Kimura, T.; Kadomatsu, K.; Muramatsu, T.; Noda, M. A receptor-like protein-tyrosine phosphatase PTPzeta/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta. J. Biol. Chem., 1999, 274 (18), 12474-12479.
78. Bouyain, S.; Watkins, D. J. The protein tyrosine phosphatases PTPRZ and PTPRG bind to distinct members of the contactin family of neural recognition molecules. Proc. Natl. Acad. Sci. USA, 2010, 107 (6), 2443-8.